Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RSV
RSV
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Motley Fool
Wed, 01/18/23 - 09:50 am
Moderna Therapeutics
RSV
Bluebird Bio
NASDAQ
Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data
Fierce Biotech
Tue, 01/17/23 - 10:52 pm
Moderna Therapeutics
RSV
vaccines
GSK
Pfizer
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
RSV
Sanofi
AstraZeneca
FDA
antibodies
nirsevimab
Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax
Fierce Biotech
Thu, 01/5/23 - 10:14 am
Moderna Therapeutics
RSV
GSK
Pfizer
vaccines
Pfizer's RSV vaccine rush gets FDA boost with priority review
Fierce Biotech
Wed, 12/7/22 - 11:45 pm
Pfizer
RSV
vaccines
FDA
priority review
RSVpreF
Pediatric health groups call for national emergency to fight respiratory illnesses
The Hill
Fri, 11/18/22 - 10:30 am
pediatrics
physicians
Joe Biden
RSV
COVID-19
Flu
Blue Lake reports positive data from Phase I RSV vaccine trial
Clinical Trials Arena
Tue, 11/8/22 - 11:08 am
Blue Lake Biotechnology
clinical trials
vaccines
BLB201
RSV
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Sanofi
AstraZeneca
RSV
nirsevimab
Europe
vaccines
With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer
Fierce Biotech
Wed, 11/2/22 - 10:25 am
GSK
Pfizer
RSV
vaccines
FDA
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
CNN
Tue, 11/1/22 - 12:12 pm
Pfizer
vaccines
RSV
maternal vaccines
clinical trials
FDA
GSK hits back in high-stakes RSV vaccine game, posting phase 3 data that suggest it has edge on Pfizer
Fierce Biotech
Thu, 10/13/22 - 09:47 am
GSK
RSV
vaccines
clinical trials
Pfizer
JNJ
Moderna Therapeutics
RSVPreF3
Sanofi, AstraZeneca win EMA support for RSV drug in babies
BioPharma Dive
Sun, 09/18/22 - 10:22 pm
AstraZeneca
Beyfortus
RSV
Europe
pediatric
infants
Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms
Fierce Pharma
Fri, 09/16/22 - 10:54 am
Sanofi
AstraZeneca
Pfizer
GSK
nirsevimab
Beyfortus
RSV
Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market
Endpoints
Thu, 08/25/22 - 11:27 am
Pfizer
vaccines
RSV
RSVpreF
Moderna CEO touts plan for triple combo respiratory shot in 'three to five years': report
Fierce Pharma
Thu, 08/11/22 - 11:53 am
Moderna Therapeutics
Stephane Bancel
vaccines
triple combo vaccine
COVID-19
RSV
Flu
Pfizer seeks to overturn three RSV vaccine patents held by GSK
Pharmaforum
Wed, 06/29/22 - 05:30 pm
vaccines
RSV
Pfizer
GSK
patents
legal
GSK hails phase 3 win for RSV vaccine in older adults, sparking race to regulators
Fierce Biotech
Fri, 06/10/22 - 10:45 am
GSK
vaccines
RSV
clinical trials
Enanta sinks to multiyear low as phase 2b RSV trial flames out
Fierce Biotech
Thu, 05/19/22 - 10:45 am
Enanta Pharmaceuticals
RSV
clinical trials
EDP-938
LabCorp becomes first company to get EUA for direct-to-consumer test for flu, RSV, COVID-19
Medtech Dive
Wed, 05/18/22 - 10:14 am
Medtech
diagnostics
COVID-19
Flu
RSV
FDA
LapCorp
Emergency Use Authorization
Starna Therapeutics emerges with financing for mRNA vaccine and therapies
Endpoints
Mon, 05/16/22 - 10:38 am
Starna Therapeutics
funding
RSV
idiopathic pulmonary fibrosis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »